Bacteria or virus inactivation device and bacteria or virus inactivation treatment method
The device uses alternating ultraviolet light intensity based on human presence to efficiently inactivate bacteria and viruses, addressing inefficiencies and safety concerns of conventional methods, ensuring safety and effective inactivation in occupied spaces.
Patent Information
- Application Number
- JP2021077287
- Authority / Receiving Office
- JP · JP
- Patent Type
- Patents
- Current Assignee / Owner
- Filing Date
- 2021-04-30
- Publication Date
- 2024-11-14
- Estimated Expiration
- 2041-04-30
AI Technical Summary
Conventional ultraviolet light-based bacteria and virus inactivation methods using germicidal lamps are inefficient and pose safety risks to humans due to direct irradiation, especially when people frequently enter or occupy the treated space, leading to incomplete inactivation and potential adverse health effects.
A bacteria or virus inactivation device that emits ultraviolet light with a peak wavelength between 190 nm and 240 nm, using a control unit to alternate between high and low intensity lighting operations based on the presence of humans, ensuring safety and effective inactivation of bacteria and viruses in both occupied and unoccupied spaces.
The device efficiently inactivates bacteria and viruses while minimizing exposure to humans, reducing power consumption, and preventing excessive irradiation, thus ensuring safety and maintaining a sanitary environment.
Smart Images

Figure 0007583367000001 
Figure 0007583367000002 
Figure 0007583367000003
Abstract
Description
[Technical field]
[0001] The present invention relates to an inactivation device for bacteria or viruses, and more particularly to an inactivation device for bacteria or viruses that utilizes ultraviolet light. The present invention also relates to a method for inactivating bacteria or viruses. [Background technology]
[0002] Conventionally, a technique for inactivating bacteria and viruses by irradiating them with ultraviolet light has been known, and because DNA exhibits the highest absorption characteristics at wavelengths of around 260 nm, ultraviolet light with a wavelength of around 254 nm, emitted from a light source such as a low-pressure mercury lamp, is often used. The method for inactivating bacteria and viruses with ultraviolet light has the advantage that sterilization can be performed simply by irradiating the space or object to be treated with ultraviolet light, without the need to spray chemicals or the like.
[0003] However, it is known that ultraviolet light of a certain wavelength band poses a risk of affecting the human body when irradiated with it. For this reason, methods and devices for inactivating bacteria and viruses present in a space so as not to irradiate people with ultraviolet light are being studied.
[0004] For example, the following Patent Document 1 describes a germicidal lamp that is installed near the ceiling in a space and irradiates ultraviolet light only near the ceiling when people are present in the space so that the ultraviolet light emitted from the germicidal lamp is not directly irradiated onto people in the space. [Prior art documents] [Patent documents]
[0005] [Patent Document 1] JP 2019-150668 A Summary of the Invention [Problem to be solved by the invention]
[0006] However, with a germicidal lamp such as that described in Patent Document 1, in cases where people frequently enter and exit the space or where people work in the space for long periods of time, the ultraviolet light is only irradiated to an area near the ceiling, and inactivation processing is only performed in a very small area that is hard to reach.
[0007] In addition, inactivation treatments that avoid people and irradiate ultraviolet light cannot inactivate bacteria or viruses that attach to people and move around. Therefore, such inactivation treatments are inefficient because bacteria or viruses that are carried by people may attach to the treated area immediately after the treatment is completed.
[0008] In view of the above problems, the present invention aims to provide a bacteria or virus inactivation device and a bacteria or virus inactivation method that can efficiently inactivate bacteria or viruses present in a space while ensuring safety for humans and animals. [Means for solving the problem]
[0009] The bacterial or viral inactivation device of the present invention comprises: A device for inactivating bacteria and viruses present in a space, A light source unit that emits ultraviolet light having a peak wavelength within a range of 190 nm or more and less than 240 nm; The lamp is characterized by having a control unit that controls the light source unit to execute a main operation mode including a first lighting operation and a second lighting operation that emits ultraviolet light having a lower light intensity than the first lighting operation.
[0010] In this specification, "inactivation" refers to a comprehensive concept of killing bacteria or viruses or deactivating their infectivity or toxicity, and "microbes" refers to microorganisms such as bacteria and fungi (molds). Hereinafter, "microbes or viruses" may be collectively referred to as "microbes, etc."
[0011] FIG. 11 is a graph showing the absorbance characteristics of proteins in the ultraviolet light region. According to FIG. 11, proteins are less likely to absorb ultraviolet light at wavelengths of 240 nm or more, and are more likely to absorb ultraviolet light at wavelengths of 240 nm or less toward 200 nm. Ultraviolet light with a wavelength of 240 nm or more easily penetrates human skin and penetrates into the skin. As a result, cells inside the human skin are easily damaged. In contrast, ultraviolet light with a wavelength of less than 240 nm is easily absorbed by the surface of human skin (e.g., the stratum corneum) and is less likely to penetrate into the skin. As a result, it is very safe for the skin.
[0012] Furthermore, for the eyes, ultraviolet light with a wavelength of less than 240 nm does not easily penetrate the cornea, so the shorter the wavelength, the safer it is.
[0013] On the other hand, when ultraviolet light with a wavelength of less than 190 nm is present, oxygen molecules in the atmosphere are photodecomposed to generate many oxygen atoms, and the oxygen molecules and oxygen atoms react to generate a lot of ozone. Therefore, it is not desirable to irradiate the atmosphere with ultraviolet light with a wavelength of less than 190 nm.
[0014] Therefore, ultraviolet light having a wavelength in the range of 190 nm or more and less than 240 nm can be said to be ultraviolet light that is highly safe for humans and animals. From the viewpoint of further increasing safety for humans and animals, the ultraviolet light emitted from the light source unit preferably has a wavelength range of 190 nm or more and 237 nm or less, more preferably 190 nm or more and 235 nm or less, and particularly preferably 190 nm or more and 230 nm or less.
[0015] The subject product of the present invention does not cause erythema or keratitis on the skin or eyes of humans or animals, and can provide the inherent sterilization and virus inactivation capabilities of ultraviolet light. In particular, unlike conventional light sources that emit ultraviolet light, it can be used in manned environments, and by installing it in manned environments indoors and outdoors, it can irradiate the entire environment, providing virus suppression and sterilization of the air and the surfaces of materials installed in the environment.
[0016] This corresponds to Goal 3 of the UN-led Sustainable Development Goals (SDGs) "Ensure healthy lives and promote well-being for all at all ages" and will contribute significantly to Target 3.3 "By 2030, end the epidemics of AIDS, tuberculosis, malaria and neglected tropical diseases, and combat hepatitis, water-borne and other communicable diseases."
[0017] As of the filing date of this application, threshold limit values (TLV: Threshold Limit Values) for each wavelength have been established for the amount of ultraviolet light irradiated to the human body per day (8 hours) by ACGIH (American Conference of Governmental Industrial Hygienists), JIS Z 8812 (Method of measurement of harmful ultraviolet radiation), etc. In other words, when ultraviolet light is used in an environment where humans are present, it is recommended that the radiation intensity and lighting time of the light source unit be determined so that the cumulative amount of ultraviolet light irradiated within a specified time period is within the standard value of the TLV.
[0018] These regulations also stipulate permissible limits for ultraviolet light with wavelengths of 190 nm or more and less than 240 nm. Therefore, even when inactivation treatment is performed using ultraviolet light with wavelengths of 190 nm or more and less than 240 nm, which poses an extremely low risk of affecting the human body, it is preferable that the ultraviolet light be irradiated to humans so that the permissible limits are not exceeded.
[0019] Therefore, the inventors of the present invention have found through extensive research that it is effective to temporarily weaken the intensity of the ultraviolet light emitted from the light source unit, thereby reducing the amount of ultraviolet light that a person is exposed to.
[0020] With the above configuration, it is possible to configure an inactivation device for bacteria or viruses that has little risk of affecting the human body. Furthermore, with the inactivation device configured as above, even in cases where people frequently enter and exit the space or where people work in the space for long periods of time, it is possible to continue the inactivation process in the space where people pass through while suppressing the amount of ultraviolet light irradiated onto people.
[0021] Furthermore, when no people are present in space 2, unnecessarily continuing irradiation of high-intensity ultraviolet light will not occur, thereby reducing, for example, power consumption and suppressing irradiation of excessive ultraviolet light that may affect plants, etc. placed in the space.
[0022] Even when the light intensity is reduced, ultraviolet light is still emitted from the inactivation device, so even if the ultraviolet light hardly reaches the walls or floor, it has been confirmed that the inactivation treatment is effective against airborne bacteria present in the space around the inactivation device. Specifically, it has been confirmed that when ultraviolet light with a wavelength of 222 nm is irradiated on human coronaviruses floating in the air, an inactivation effect of approximately 1 Log is obtained with 0.56 mJ.
[0023] In addition, low-pressure mercury lamps emitting ultraviolet light with a wavelength of 254 nm, which have been the mainstream germicidal lamps in the past, have had the problem that it is difficult to change the intensity of the emitted ultraviolet light while keeping it on. For this reason, there has not been sufficient research into methods for changing the intensity of the emitted ultraviolet light in relation to inactivation treatment using ultraviolet light.
[0024] From the above viewpoint, it is more preferable that the main emission wavelength range including the peak wavelength of the ultraviolet light is within the range of 190 nm or more and less than 240 nm. The main emission wavelength range here refers to a wavelength that shows an emission intensity of 50% or more of the emission intensity of the peak wavelength. More preferably, it is 30% or more, and particularly preferably, it is 10% or more.
[0025] In order to improve the efficiency of ultraviolet light utilization while further enhancing safety, the main emission wavelength range including the peak wavelength is preferably within the range of 190 nm or more and 237 nm or less, more preferably within the range of 190 nm or more and 235 nm or less, and particularly preferably within the range of 190 nm or more and 230 nm or less.
[0026] In addition, in order to more effectively suppress the generation of ozone, the main emission wavelength range including the peak wavelength is set within a wavelength range of 200 nm or more and 237 nm or less, more preferably within a wavelength range of 200 nm or more and 235 nm or less, and even more preferably within a wavelength range of 200 nm or more and 230 nm or less.
[0027] In the inactivation apparatus, The control unit may be configured to control the light source unit in the main operation mode so that the time period for which the second lighting operation is continued is longer than the time period for which the immediately preceding first lighting operation is continued.
[0028] In addition, in the inactivation device, The control unit may be configured to control the light source unit such that, in the main operation mode, the first lighting operation and the second lighting operation are executed cyclically.
[0029] In this specification, the term "periodic" refers to repeating the first lighting operation and the second lighting operation for a preset maintenance time. Note that the time for maintaining the first lighting operation and the second lighting operation is allowed to vary within a range that may occur depending on the timer, circuit configuration, etc. installed.
[0030] In addition, in the main operation mode, the cycle for switching between the first lighting operation and the second lighting operation does not have to be constant at all times, and may be changed, for example, when the presence of a person is detected in the space or when a predetermined time has elapsed.
[0031] With the above configuration, when inactivation processing is performed in a space where people are present, the amount of ultraviolet light irradiated onto people is reduced compared to when the first lighting operation is always performed, thus realizing an inactivation device that can inactivate bacteria and the like in a space more safely.
[0032] Furthermore, when the inactivation process is performed in a space where no people are present, power consumption is reduced compared to when the first lighting operation is always performed, and irradiation of excessive ultraviolet light that could affect plants, etc. placed in the space is further reduced.
[0033] The control unit of the inactivation device, in the main operation mode, a first control pattern in which the first lighting operation and the first extinguishing operation are alternately performed; The light source may be configured to execute control including a second control pattern in which the second lighting operation and the extinguishing operation are alternately performed, or the second lighting operation is continued.
[0034] Furthermore, the inactivation device A human detection unit is provided to detect whether or not a human is present within a predetermined area, The control unit may be configured to execute the first control pattern when the human detection unit detects that a human is not present, and to execute the second control pattern when the human detection unit detects that a human is present.
[0035] With the above configuration, for example, a first control pattern can be configured to be executed to perform a first lighting operation depending on whether or not there is a person in the space, or during a time period when it is assumed that there is no person present.
[0036] As in the above configuration, if a human detection unit using a human sensor or the like is provided, it becomes possible to configure the system to check whether or not a person is present in the space and switch the control pattern accordingly.
[0037] In addition, a configuration may be adopted in which the control pattern is switched using a component other than the human detection unit. For example, a timer may be provided in the inactivation device so that the device switches from the second control pattern to the first control pattern when it is expected that no people will be present (typically late at night).
[0038] In addition, the control unit of the inactivation device, in the main operation mode, a third control pattern in which the first lighting operation and the second lighting operation are alternately performed; The lamp may be configured to execute control that alternates between the first lighting operation and the second lighting operation and includes a fourth control pattern in which the frequency of the second lighting operation per unit time is higher than that of the third control pattern.
[0039] Furthermore, the inactivation device A human detection unit is provided to detect whether or not a human is present within a predetermined area, The control unit may be configured to execute the third control pattern when the human detection unit detects that a human is not present, and to execute the fourth control pattern when the human detection unit detects that a human is present.
[0040] In the inactivation apparatus, The control unit may be configured to transition from the main operation mode to a secondary operation mode different from the main operation mode when it detects that a predetermined condition is satisfied.
[0041] The "secondary operation mode" referred to here is not only a temporary lighting operation performed to ensure safety when an abnormality occurs in the inactivation device, but also a mode in which the lighting of the light source unit is controlled using a control pattern different from that of the main operation mode depending on the number of people present in the space, the time of day, the opening status of windows and doors, etc.
[0042] There are cases where it is not desirable to always perform the inactivation process in a specified mode. For example, there are cases where it is desirable to continue the inactivation process at least around the device, even if people with a constitution that shows an allergic reaction to ultraviolet light or people who dislike being exposed to ultraviolet light enter the room. Also, there are cases where an optimal operating mode is required depending on the environmental conditions where the inactivation process is performed (for example, the frequency of people coming and going, and the time of day or night).
[0043] Therefore, with the above configuration, for example, when a signal to refuse irradiation of ultraviolet light is received as an example of a predetermined condition, the main operation mode is temporarily switched to the secondary operation mode, and if it is difficult to continue the main operation mode, a different operation or a temporary operation can be performed. As a temporary operation, for example, irradiation of ultraviolet light at a very low intensity or irradiation of ultraviolet light for about a few seconds once an hour can be considered.
[0044] Examples of the predetermined condition include when a wireless signal is received that rejects irradiation of ultraviolet light, or when the presence of a person or animal is detected within a range of several centimeters from the inactivation device.
[0045] The secondary operation mode may be a mode that the control unit determines to switch to depending on the state of the device itself, such as a mode in which lighting control is performed to temporarily increase the light intensity when an element such as an excimer lamp or LED mounted as a light source unit deteriorates and the intensity of the emitted ultraviolet light falls below a predetermined value.
[0046] The method for inactivating a bacterium or a virus of the present invention comprises the steps of: A method for inactivating bacteria and viruses present in a space, comprising: The method is characterized by including a main processing step of performing a first lighting operation in which ultraviolet light having a peak wavelength within the range of 190 nm or more and less than 240 nm is irradiated onto a processing target area, and a second lighting operation in which ultraviolet light having a peak wavelength within the range of 190 nm or more and less than 240 nm and a lower light intensity than that of the first lighting operation is irradiated onto the processing target area.
[0047] The inactivation method includes the steps of: The main treatment step may be performed by a light source that emits ultraviolet light and is installed in the ceiling or upper area of the space.
[0048] In this specification, the "upper region of the space" refers to a region whose height from the floor is higher than the height of a person, specifically, a region whose height from the floor is 2 m or more. Methods for installing the inactivation device in the upper region of the space include installing it on a wall included in the upper region of the space, or fixing it to a pole that is 2 m or higher.
[0049] The illuminance of the ultraviolet light emitted from the light source is inversely proportional to the square of the distance from the light source. For this reason, it is preferable to maintain a certain distance between the light source and a person so that the ultraviolet light is not irradiated onto the person immediately after it is emitted from the light source.
[0050] If a light source is installed on the floor or table within a space, there is a risk that people may approach the light source itself, and the amount of irradiation may quickly reach the allowable limit of the above-mentioned standard.
[0051] In contrast, with the above configuration, most people can ensure that their heads are spaced several tens of centimeters from the ceiling even when they are standing upright. In other words, unless a person intentionally reaches out their arms toward the light source, there is no risk of being exposed to high-intensity ultraviolet light.
[0052] Therefore, by using the above method, inactivation treatment can be performed in a space more safely compared to when the device is placed on the floor or table.
[0053] In addition, in the above inactivation treatment method, The main processing step may be a step in which the first lighting operation and the second lighting operation are performed cyclically.
[0054] In the above inactivation treatment method, In the main processing step, the time period during which the second lighting operation continues may be longer than the time period during which the immediately preceding first lighting operation continues.
[0055] In the main processing step, the first lighting operation and the second lighting operation may be performed cyclically.
[0056] In the inactivation treatment step, The main processing step includes: a first processing step of alternately performing the first lighting operation and turning off the light; The lighting device may include a second processing step of alternately performing the second lighting operation and turning off the light, or continuing the second lighting operation.
[0057] In the inactivation treatment step, The main processing step includes: a third processing step of alternately performing the first lighting operation and the second lighting operation; The method may include a fourth processing step in which the second lighting operation and the first lighting operation are alternately performed, and the frequency of the second lighting operation per unit time is higher than that of the third processing step.
[0058] The inactivation method includes the steps of: The method may include a sub-processing step in which irradiation with ultraviolet light is performed by a process different from the main process step when it is detected that a predetermined condition is satisfied. Effect of the Invention
[0059] According to the present invention, a bacteria or virus inactivation device and a bacteria or virus inactivation method are realized that can efficiently inactivate bacteria or viruses present in a space while ensuring safety for humans and animals. [Brief description of the drawings]
[0060] [Figure 1A] 1 is a schematic diagram of one embodiment of an inactivation device. [Figure 1B] 1 is a schematic diagram of one embodiment of an inactivation device. [Diagram 2] FIG. 1B is a view of the inactivation device of FIG. 1A from the -Z side. [Diagram 3] 1B is a cross-sectional view of the inactivation device of FIG. 1A as viewed in the X direction. [Figure 4] 1B is a cross-sectional view of the inactivation device of FIG. 1A as viewed in the Y direction. [Diagram 5] 4 is a timing chart showing a change in light intensity of ultraviolet light in the vicinity of the exit window. [Figure 6] 4 is a timing chart showing a change in light intensity of ultraviolet light in the vicinity of the exit window. [Figure 7] 4 is a timing chart showing a change in light intensity of ultraviolet light in the vicinity of the exit window. [Figure 8] 4 is a timing chart showing a change in light intensity of ultraviolet light in the vicinity of the exit window. [Figure 9] 4 is a timing chart showing a change in light intensity of ultraviolet light in the vicinity of the exit window. [Figure 10] 4 is a timing chart showing a change in light intensity of ultraviolet light in the vicinity of the exit window. [Figure 11] 1 is a graph showing the absorbance characteristics of proteins in the ultraviolet light region. [Figure 12] This is the result of a comparison between continuous lighting and intermittent lighting using a light source that emits ultraviolet light with a central wavelength of 254 nm. [Figure 13] This is the result of a comparison between continuous lighting and intermittent lighting using a light source that emits ultraviolet light with a central wavelength of 222 nm. [Figure 14] This is the result of a comparison between continuous lighting and intermittent lighting using a light source that emits ultraviolet light with a central wavelength of 207 nm. DETAILED DESCRIPTION OF THE PREFERRED EMBODIMENTS
[0061] The bacteria or virus inactivation device and the inactivation method of the present invention will be described below with reference to the drawings. Note that the drawings are all schematic illustrations, and the dimensional ratios and numbers in the drawings do not necessarily correspond to the actual dimensional ratios and numbers.
[0062] [Inactivation device] 1A and 1B are schematic diagrams showing an embodiment of the inactivation device 1, in which Fig. 1A shows the state of the inactivation process when a human sensor 11 (see Fig. 2) described later detects a human, and Fig. 1B shows the state of the inactivation process when no human is detected. As shown in Fig. 1A and 1B, the inactivation device 1 of this embodiment is installed on the ceiling so as to emit ultraviolet light L1 toward the floor surface in the space 2. As a result, the ultraviolet light L1 is emitted from the upper region toward the lower region.
[0063] As will be described in detail in the explanation of the control method, Fig. 1A shows a state in which, in the second lighting operation state in which ultraviolet light L1 having a relatively low light intensity is emitted, bacteria floating in the space 2 are mainly inactivated. And Fig. 1B shows a state in which, in the first lighting operation state in which ultraviolet light L1 having a relatively high light intensity is emitted, bacteria floating in the space 2 are inactivated and bacteria adhering to a desk, floor, etc. are mainly inactivated.
[0064] Fig. 2 is a drawing of the inactivation device 1 of Fig. 1A as viewed from the -Z side, Fig. 3 is a cross-sectional view of the inactivation device 1 of Fig. 1A as viewed in the X direction, and Fig. 4 is a cross-sectional view of the inactivation device 1 of Fig. 1A as viewed in the Y direction. As shown in Fig. 2, the inactivation device 1 of this embodiment includes a housing 10 in which a light exit window 10a is formed. And, as shown in Fig. 3, the housing 10 includes a light source unit 20 and a control unit 30 inside.
[0065] Although the inactivation apparatus 1 of this embodiment will be described as being configured to be used in a state in which it is installed on the ceiling, the inactivation apparatus 1 of the present invention may also be fixed to a floor, a desk, or even a pole, etc., and used by installing it in the upper region H1 (see FIG. 1A) of the space 2. When used by fixing it to a pole, the inactivation apparatus 1 is preferably installed in the space 2 at a height of 2 m or more from the floor.
[0066] In the following explanation, the direction in which the ultraviolet light L1 is emitted is defined as the Z direction, the tube axis direction of the tube body 21 of the excimer lamp described later as shown in FIG. 3 is defined as the Y direction, and the direction perpendicular to the Y direction and the Z direction is defined as the X direction.
[0067] In addition, when expressing a direction, if a distinction is made between positive and negative directions, a positive or negative sign is added, such as "+Z direction" and "-Z direction." When expressing a direction without distinguishing between positive and negative directions, it is simply written as "Z direction."
[0068] As shown in FIG. 2, the housing 10 has a light exit window 10a through which the ultraviolet light L1 is emitted to the outside, and a human presence sensor 11 corresponding to a human detection unit is provided on the surface on which the light exit window 10a is formed.
[0069] The light exit window 10a is formed on a wall surface parallel to the XY plane from a material that is transparent to the ultraviolet light L1 emitted from the light source unit 20 described below. Specific materials that may be used for the light exit window 10a include, for example, quartz glass and sapphire glass. The light exit window 10a may also be an opening.
[0070] In order to prevent the influence on the human body and improve safety, the light exit window 10a in this embodiment is preferably configured to suppress the light intensity in the wavelength range of 240 nm to 280 nm. As an example of a specific configuration, the light exit window 10a in this embodiment is provided with an optical filter (not shown). However, if the light intensity in the wavelength range of 240 nm to 280 nm in the spectrum of the ultraviolet light L1 emitted from the light source unit 20 is sufficiently low, the optical filter may not be provided. In addition, the configuration for suppressing the light intensity in the above wavelength range may be realized by a mechanism or optical system provided separately from the housing 10 and the light exit window 10a, in addition to the optical filter provided in the light exit window 10a.
[0071] Furthermore, the inactivation device 1 of this embodiment is provided with a human presence sensor 11 that detects a person by using infrared light on the side surface of the housing 10. Area A1 shown in Figures 1A and 1B indicates an area where the human presence sensor 11 can receive infrared light, that is, an area where the human presence sensor 11 can detect a person.
[0072] The human sensor 11 in this embodiment is an infrared sensor, but a sensor that detects the presence of a person using, for example, a proximity sensor or a distance sensor may be used. The inactivation device 1 may be configured to employ the above-mentioned sensor as the human sensor 11 and detect the presence of a person as well as animals and specified objects.
[0073] The light source unit 20 in this embodiment is configured with an excimer lamp including a tube 21 and two electrodes 22 arranged on the outer surface of the tube 21, as shown in FIG.
[0074] Krypton (Kr) and chlorine (Cl) are sealed in the tube 21 as light emitting gases, and when a voltage equal to or greater than a predetermined threshold is applied between the electrodes 22, ultraviolet light L1 with a peak wavelength of 222 nm is emitted from the tube 21. Note that, although the light source unit 20 in the first embodiment is configured with an excimer lamp, it may be configured with, for example, an LED, as long as it is a light source that can emit ultraviolet light L1 in the above-mentioned wavelength band that can be used for inactivation treatment of bacteria, etc.
[0075] As shown in Figures 1A and 1B, the ultraviolet light L1 emitted from the light source unit 20 is emitted from the light exit window 10a to the outside of the housing 10. As shown in Figures 1A and 1B, the inactivation device 1 is installed on the ceiling of the space 2 and irradiates the ultraviolet light L1 toward the floor (-Z side), which is the treatment target area. Note that the wall in the space 2 may be the treatment target area, and the treatment target area may be the top of a desk or the like installed in the space 2.
[0076] As shown in FIG. 3, the control unit 30 in this embodiment includes a calculation unit 31 that calculates the value of power pw to be supplied to the light source unit 20, a memory unit 32 in which control pattern data d1 is stored, and a drive unit 33 that supplies power pw to the light source unit 20.
[0077] The calculation unit 31 in this embodiment is a calculation circuit mounted in the housing 10, and specific examples include a CPU and an MPU. The drive unit 33 is an electric circuit that generates power pw for driving the light source unit 20. The storage unit 32 may be a flash memory, a semiconductor memory, or the like, but from the viewpoint of the presence or absence of a process for storing the control pattern data d1 every time the power is turned on, it is preferable that the storage unit 32 is a non-volatile memory. The storage unit 32 may also be an external memory that is connected directly or via a cable or the like.
[0078] When a signal s1 indicating that a person has been detected or no longer detected is input from the human presence sensor 11, the calculation unit 31 reads data d1 relating to a control pattern corresponding to the signal s1 from the storage unit 32. When the calculation unit 31 reads the data d1 from the storage unit 32, the calculation unit 31 outputs a signal s2 specifying the value of power pw to be supplied to the light source unit 20 to the drive unit 33 based on the data d1.
[0079] The driving unit 33 generates the electric power pw to be supplied to the light source unit 20 based on the signal s2, and supplies the electric power pw to the electrodes 22 included in the light source unit 20.
[0080] In this embodiment, data d1 of a plurality of control patterns is stored in the storage unit 32. Specific controls of these will be described below.
[0081] In this embodiment, the control unit 30 is described as being mounted within a housing, but the control unit 30 may also be an external device such as a PC or tablet configured to communicate with the inactivation device 1 via wired or wireless communication.
[0082] [Control method] Hereinafter, the control of the light source unit 20 by the control unit 30 will be described in detail. Note that the control patterns described below are merely examples assumed based on the concept of the inactivation method of the present invention. In addition, the control unit 30 in this embodiment can be assumed to automatically control the light source unit 20.
[0083] The inactivation device 1 of this embodiment is configured to execute an operation pattern including an inactivation processing operation including a first lighting operation that emits ultraviolet light L1 having a relatively high light intensity and a second lighting operation that emits ultraviolet light L1 having a relatively low light intensity.
[0084] The first lighting operation, which emits ultraviolet light L1 with a relatively high light intensity, is an operation of irradiating the ultraviolet light L1 onto a desk or floor, as shown in Figure 1B, and is performed to inactivate bacteria, etc. floating in the space 2, as well as to primarily inactivate bacteria, etc. attached to the floor surface or the top surface of the desk.
[0085] The second lighting operation, which emits ultraviolet light L1 with a relatively low light intensity, is performed to inactivate bacteria and the like floating in space 2 while suppressing irradiation of ultraviolet light L1 to people, as shown in FIG. 1A.
[0086] Below, examples of inactivation processing by combining the first lighting operation and the second lighting operation are described, but all of the examples are control methods that combine processes with different light intensities of the ultraviolet light L1 emitted from the inactivation device 1 to efficiently perform inactivation processing of bacteria, etc. present in the space 2.
[0087] As the control method, for example, a control pattern in which the first lighting operation and the second lighting operation are switched depending on whether or not a person is present in the space 2 by a human detection unit (human sensor 11 in this embodiment) that detects whether or not a person is present in a predetermined area, or a control pattern in which the first lighting operation and the second lighting operation are alternately switched during a period in which the human detection unit does not detect a person, may be considered. Furthermore, a control method in which the first lighting operation and the second lighting operation are alternately switched during a period in which the human detection unit detects a person may also be used.
[0088] Furthermore, a control method that appropriately combines a control pattern (first control pattern) in which a first lighting operation and an extinguishing operation are periodically repeated and a control pattern (second control pattern) in which a second lighting operation and an extinguishing operation are periodically repeated may be adopted. As with the switching control between the first lighting operation and the second lighting operation, the control pattern may be switched depending on whether or not a person is present in the space 2, or the first control pattern and the second control pattern may be alternately switched during a period in which the human detection unit detects a person or during a period in which the human detection unit does not detect a person. Examples of various possible control methods are shown below.
[0089] In an embodiment in which the light is maintained on by executing the first and second lighting operations without being turned off during operation, the inactivation process of bacteria, etc. floating in space 2 is constantly continued, so that bacteria, etc. can be inactivated more effectively compared to a method in which the light is turned on and off.
[0090] Specifically, in the case of a method in which the light is turned on and off repeatedly, when bacteria, etc., flow in successively from outside the space 2, the inactivation process of the area irradiated with the ultraviolet light L1 is sufficient, but the inactivation process of the bacteria, etc., floating in the space 2 cannot keep up. In such a case, a control method in which the light is kept on and the bacteria, etc., floating in the space 2 are continuously inactivated, making it possible to inactivate the bacteria, etc., that flow in successively as needed, and to maintain a hygienic environment.
[0091] In the following examples, a main operation mode is described, which is the normal operation in which the first lighting operation and the second lighting operation are executed. However, the inactivation device 1 may be configured to transition to a secondary operation mode having a different control pattern and operation from the main operation mode when certain conditions are met, such as a decrease in the output of the light source unit 20.
[0092] A condition for transitioning to the secondary operation mode is, for example, when a decrease in the intensity of the ultraviolet light L1 emitted from the light source unit 20 is detected due to deterioration of the light source unit 20. In such a case, the control unit 30 transitions to the secondary operation mode and increases the value of the power pw supplied by the drive unit 33 to perform the inactivation process, or stops the supply of power pw to the light source unit 20.
[0093] Example 1 Fig. 5 is a timing chart showing a change in the light intensity of the ultraviolet light L1 near the light exit window 10a in the first embodiment. Fig. 5 shows a timeline chart (a) relating to whether or not a person is detected, and a timing chart (b) relating to the light intensity. The timeline chart (a) in Fig. 5 shows a period in which the human sensor 11 does not detect a person as a first period X1, and a period in which the human sensor 11 detects a person as a second period X2. Note that in the first embodiment, an operation in which the human sensor 11 detects whether or not a person is present in the space 2 and the control pattern is switched is described as a main operation mode.
[0094] The switching between the first period X1 and the second period X2 may be performed under a condition other than the detection of a human by the human sensor 11. The condition for switching between the first period X1 and the second period X2 may be, for example, the detection of the passage of a predetermined time by a timer or the detection of the arrival of a predetermined time.
[0095] The vertical axis in the timing chart (b) of Figure 5 indicates light intensity, with the period when the light intensity is at a relatively high level (i1) corresponding to the execution period of control pattern P1, and the period when the light intensity is at a relatively low level (i2) corresponding to the execution period of control pattern P2.
[0096] In this embodiment, the control unit 30 is configured to switch to control pattern P2 when the human presence sensor 11 detects the presence of a person, and to execute control pattern P1 when the human presence sensor 11 no longer detects the presence of a person. The timing chart shown in Fig. 5 illustrates the time around time t1 when the human presence sensor 11 no longer detects the presence of a person and switches from a state in which control pattern P2 is being executed to a state in which control pattern P1 is being executed.
[0097] The control pattern P1 in the first embodiment is a pattern in which the control unit 30 controls the light source unit 20 to emit ultraviolet light L1 of a predetermined intensity, and inactivates bacteria and the like floating in the space 2 as well as bacteria and the like attached to the surfaces of objects such as desks and floors. The control pattern P1 is a pattern in which a first lighting operation of lighting with a predetermined light intensity and turning off the light are periodically repeated, and corresponds to the first control pattern (first processing step).
[0098] In Example 1, in the control pattern P1 shown in FIG. 5, the period T1 for repeating the first lighting operation and extinction is set to 45 seconds, the time T2 for which the first lighting operation continues is set to 15 seconds, and the time T3 for which the extinction continues is set to 30 seconds.
[0099] Control pattern P2 in Example 1 is a mode in which, when a person is present in space 2, the intensity of the ultraviolet light L1 emitted from the light source unit 20 is reduced to suppress the amount of ultraviolet light L1 irradiated to the person, while mainly inactivating bacteria and the like floating in space 2. Control pattern P2 is a pattern in which a second lighting operation is performed in which the light is turned on at a lower light intensity than the first lighting operation in control pattern P1, and corresponds to the second control pattern (second processing step).
[0100] In the control pattern P2 in the first embodiment, as shown in FIG. 5, the control unit 30 continuously supplies the power pw required for the second lighting operation to the light source unit 20, and the second lighting operation is continuously performed.
[0101] By executing the above control method, the inactivation device 1 executes the control pattern P2 when a person is present in the space 2, and performs the inactivation process by the second lighting operation with a lower light intensity than the first lighting operation. Therefore, when a person is present in the space 2, the amount of ultraviolet light L1 irradiated to the person is reduced compared to when the first lighting operation is always executed.
[0102] Furthermore, when no people are present in the space 2, the irradiation of high-intensity ultraviolet light L1 will not be continued unnecessarily, thereby reducing, for example, power consumption and suppressing the irradiation of excessive ultraviolet light L1 that may affect plants, etc. placed in the space 2.
[0103] In particular, since bacteria and the like adhering to the surfaces of objects such as desks and floors remain in place, the inactivation process can be effectively carried out even in the case of a control method such as control pattern P1 in which the first lighting operation in which the light is turned on at a predetermined light intensity is performed intermittently. In particular, it has been found that ultraviolet light with a wavelength of less than 240 nm has the effect of inhibiting photoreactivation of bacteria, and the effect of the inactivation process is unlikely to be impaired even with intermittent lighting operation.
[0104] Therefore, the inactivation device 1 can efficiently inactivate bacteria and the like present in the space 2 while ensuring safety for people and animals.
[0105] Furthermore, it was found that ultraviolet light with a wavelength of less than 240 nm has the effect of inhibiting bacterial photoreactivation, and the effect of the inactivation treatment is unlikely to be impaired even in an environment where visible light is irradiated.
[0106] The inactivation device 1 of this embodiment is configured to execute only the main operation mode (main processing step) including the first lighting operation and the second lighting operation, and all operations described below are described as control patterns of the main operation mode. However, the inactivation device 1 of this embodiment may be configured so that the control unit 30 transitions to a secondary operation mode (secondary processing step) different from the main operation mode when a predetermined condition is satisfied. The secondary operation mode is as described above.
[0107] Example 2 The control method of the inactivation apparatus 1 of the present invention will be described below, focusing on the differences from the first embodiment.
[0108] Fig. 6 is a timing chart showing a change in the light intensity of the ultraviolet light L1 near the light exit window 10a in Example 2. Fig. 6 shows a timeline chart (a) relating to whether or not a person is detected, and a timing chart (b) relating to the light intensity. Figure 6 The vertical axis in the timing chart (b) indicates light intensity, and the period during which the light intensity level (i1) and the light intensity level (i2) are repeated corresponds to the execution period of control pattern P3, and the period during which the light intensity level (i2) is relatively low corresponds to the execution period of control pattern P4. Note that in the second embodiment, the execution periods of control pattern P3 and control pattern P4 are described as main operation modes.
[0109] Control pattern P3 in Example 2 is similar to control pattern P1 in Example 1, and is a pattern in which the control unit 30 controls the light source unit 20 to emit ultraviolet light L1 of a predetermined intensity, and inactivates bacteria, etc. floating in the space 2 as well as bacteria, etc. adhering to the floor of the space 2. Control pattern P3 corresponds to a third control pattern (third processing step) in which the first lighting operation and the second lighting operation are periodically repeated, as shown in Fig. 6.
[0110] The control pattern P4 in the second embodiment corresponds to the second control pattern (second process step) in which the second lighting operation is continuously performed similarly to the first embodiment, as shown in FIG.
[0111] By executing the above control method, the time period during which the light source unit 20 is completely turned off can be reduced, and the inactivation process of bacteria and the like floating in the space 2 can be continuously performed, thereby maintaining a sanitary state in the space 2. Furthermore, by reducing the time period during which the light is turned off, the possibility of failing to turn on again and being unable to continue the inactivation process is reduced.
[0112] Example 3 The control method of the inactivation apparatus 1 of the present invention will be described below, focusing on the differences from the first and second embodiments.
[0113] Fig. 7 is a timing chart showing a change in light intensity of the ultraviolet light L1 near the light exit window 10a in the third embodiment. Fig. 7 shows a timeline chart (a) showing whether a person is detected and a timing chart (b) showing the light intensity. The vertical axis in the timing chart (b) in Fig. 7 shows the light intensity, and the section where the light intensity is relatively high (i1) corresponds to the execution period of the control pattern P5, and the section where the light intensity is relatively low (i2) corresponds to the execution period of the control pattern P6. In the third embodiment, the execution periods of the control patterns P5 and P6 are described as the main operation modes.
[0114] As shown in FIG. 7, the control pattern P5 in the third embodiment corresponds to a first control pattern (first processing step) in which the control unit 30 periodically repeats a first lighting operation and an extinguishing operation, similar to the control pattern P1 in the first embodiment.
[0115] The control pattern P6 in the third embodiment corresponds to a second control pattern (second process step) in which the second lighting operation and extinguishing are periodically repeated as shown in FIG.
[0116] In Example 3, in the control pattern P6 shown in FIG. 7, the period T4 for repeating the second lighting operation and extinction is set to 60 seconds, the time T5 for continuing the second lighting operation is set to 50 seconds, and the time T6 for continuing the extinction is set to 10 seconds.
[0117] By carrying out the above control method, the overall lighting time of the light source unit 20 is reduced, and therefore the life of the light sources constituting the light source unit 20 is extended as compared to the above-mentioned first and second embodiments.
[0118] Example 4 The control method of the inactivation apparatus 1 of the present invention will be described below, focusing on the differences from the first, second and third embodiments.
[0119] FIG. 8 is a timing chart showing a change in the light intensity of the ultraviolet light L1 near the light exit window 10a in the fourth embodiment. FIG. 8 shows a timeline chart (a) showing whether a person is detected and a timing chart (b) showing the light intensity. The vertical axis in the timing chart (b) in FIG. 8 shows the light intensity, and the section in which the light intensity is relatively high (i1) corresponds to the execution period of the control pattern P7, and the section in which the light intensity is relatively high (i1) and the light intensity is relatively low (i2) corresponds to the execution period of the control pattern P8. In the fourth embodiment, the execution period of the control pattern P8 is described as the main operation mode, but the execution period of the control pattern P7 and the execution period of the control pattern P8 may be the main operation mode.
[0120] The control pattern P7 in the fourth embodiment corresponds to a second control pattern (second process step) in which the second lighting operation and turning off are periodically repeated as shown in Fig. 8. The control pattern P8 in the fourth embodiment is a pattern in which the lighting state of the first lighting operation is maintained for a longer period of time than in the first embodiment.
[0121] As shown in FIG. 8, the control pattern P8 in the fourth embodiment corresponds to a third control pattern (third processing step) in which the control unit 30 periodically repeats the first lighting operation and the second lighting operation, similar to the control pattern P3 in the second embodiment.
[0122] In the fourth embodiment, in the control pattern P7 shown in FIG. 8, the time T7 for which the first lighting operation continues is set to 600 seconds.
[0123] By implementing the above control method, the amount of ultraviolet light L1 irradiated to a person is reduced while the time for irradiating high-intensity ultraviolet light L1 to the space 2 is extended, thereby achieving a higher inactivation effect than in Examples 1 to 3.
[0124] In addition, in the control pattern P7, by extending the duration of the high-intensity ultraviolet light L1, the bacteria adhering to the surface of the object can be inactivated to the required level in a shorter time. After the irradiation time sufficient for the inactivation process has elapsed, the light may be turned off as shown in FIG.
[0125] Example 5 The control method of the inactivation apparatus 1 of the present invention will be described below, focusing on the differences from the first to fourth embodiments.
[0126] Fig. 9 is a timing chart showing a change in the light intensity of the ultraviolet light L1 near the light exit window 10a in Example 5. Fig. 9 shows a timeline chart (a) showing whether a person is detected or not, and a timing chart (b) showing the light intensity. The vertical axis in the timing chart (b) in Fig. 9 shows the light intensity.
[0127] As shown in FIG. 9, the fifth embodiment is a pattern in which a relatively high light intensity level (i1) and a relatively low light intensity level (i2) are periodically repeated. The period in which the frequency of the relatively low light intensity level (i2) per unit time is high corresponds to the execution period of the control pattern P9, and the period in which the frequency of the relatively low light intensity level (i2) per unit time is low corresponds to the execution period of the control pattern P10. That is, the frequency of the second lighting operation per unit time is higher in the control pattern P9 than in the control pattern P10, and the control pattern P9 corresponds to the third control pattern (third processing step), and the control pattern P10 corresponds to the fourth control pattern (fourth processing step). In the fifth embodiment, the execution period of the control pattern P9 is described as the main operation mode, but the execution period of the control pattern P9 and the execution period of the control pattern P10 may be the main operation mode.
[0128] In Example 5, the control pattern P10 shown in Fig. 9 has the same time setting as the control pattern P3 in Example 1. In addition, in the control pattern P9, the cycle T8 for repeating the first lighting operation and the second lighting operation is set to 30 seconds, the time T9 for which the first lighting operation continues is set to 15 seconds, and the time T10 for which the second lighting operation continues is set to 15 seconds.
[0129] By executing the above control method, the amount of irradiation of ultraviolet light L1 irradiated to a person is suppressed while the time for irradiating high-intensity ultraviolet light L1 to the space 2 is lengthened, so that a higher inactivation effect can be obtained compared to Examples 1 to 3. Furthermore, since the time period during which the light source unit 20 is completely turned off is reduced, it is possible to continuously perform the inactivation process of bacteria and the like floating in the space, and it is easy to maintain a sanitary state in the space 2. Furthermore, by reducing the time period during which the light is turned off, the possibility of failing to turn on again and being unable to continue the inactivation process is reduced.
[0130] Example 6 The control method of the inactivation apparatus 1 of the present invention in Example 6 will be described, focusing on the differences from Examples 1 to 5.
[0131] Fig. 10 is a timing chart showing a change in the light intensity of the ultraviolet light L1 near the light exit window 10a in Example 6. Fig. 10 shows a timeline chart (a) showing whether a person is detected or not, and a timing chart (b) showing the light intensity. The vertical axis in the timing chart (b) of Fig. 10 shows the light intensity.
[0132] As shown in FIG. 10, the sixth embodiment is a pattern in which a relatively high light intensity level (i1) and a relatively low light intensity level (i2) are periodically repeated, and the time during which the relatively low light intensity level (i1) is maintained and the time during which the relatively low light intensity level (i2) is maintained are not changed. For the sake of distinction, the period during which the human sensor 11 does not detect a person corresponds to the execution period of the control pattern P11, and the period during which the human sensor 11 detects a person corresponds to the execution period of the control pattern P12. In the sixth embodiment, the execution period of the control pattern P11 is described as the main operation mode, but the execution period of the control pattern P11 and the execution period of the control pattern P12 may be the main operation mode. Specifically, for example, the control pattern in which the first lighting operation and the second lighting operation are alternately switched during the period during which the human detection unit (the human sensor 11 in the sixth embodiment) does not detect a person may be the main operation mode, and the control pattern in which the first lighting operation and the second lighting operation are alternately switched during the period during which the human detection unit detects a person may be the main operation mode.
[0133] Even in the method of Example 6, the amount of ultraviolet light L1 irradiated to a person is suppressed compared to a control method in which the first lighting operation is always continued. Also, since the inactivation process of bacteria, etc. floating in the space 2 is always continued, it is possible to more effectively inactivate bacteria, etc. compared to a method in which the lighting operation and the extinguishing operation are performed. Moreover, in the method of Example 6, since it is not necessary to distinguish whether a person is detected or not, a human detection unit that detects whether a person is present in a specified area is not necessarily required.
[0134] Examples of control methods have been described above, but as mentioned above, each embodiment is merely a part of the examples that can be implemented by the present invention, and the control method of the present invention is not limited to the above-mentioned methods, and the configuration of the inactivation device 1 is not limited to the above-mentioned configuration.
[0135] Other specific examples include a configuration in which a control pattern (first control pattern or third control pattern) is switched to intensively perform inactivation processing only during the late night hours in a workplace space, or a configuration in which a control pattern is switched to another control pattern (second control pattern or fourth control pattern) when a person turns off the lights in the room or closes the window curtains, causing the brightness to fall below a certain level.
[0136] In the above explanation, the control pattern of repeating the first lighting operation and the second lighting operation, and the control pattern of repeating the lighting operation and the extinguishing operation have been described as control patterns that periodically repeat each operation, but the switching between each operation may be configured to gradually change over time.
[0137] For example, the first lighting operation may be performed for a long time at first, and then the first lighting operation and the extinguishing operation may be repeated to match the movement of bacteria, etc. due to natural convection. Also, a control pattern may be executed that further includes an operation of irradiating ultraviolet light L1 with a light intensity different from that of the first lighting operation and the second lighting operation.
[0138] In the above explanation, the control performed by the control unit 30 is described as the main operation mode regardless of whether the human presence sensor 11 detects the presence of a person or not, but the mode executed when the human presence sensor 11 detects the presence of a person may also be the main operation mode.
[0139] The light intensity of the first lighting operation and the second lighting operation is appropriately set according to the installation conditions under which the inactivation device is used. For example, the appropriate difference in light intensity varies depending on the height of the ceiling on which the device is installed. As an example, the second lighting operation may control the light intensity of the ultraviolet light at the light exit window 10a to 80% or less of that in the first lighting operation. Also, the second lighting operation may control the light intensity of the ultraviolet light at the light exit window 10a to 50% or less of that in the first lighting operation. Also, the second lighting operation may control the light intensity of the ultraviolet light at the light exit window 10a to 20% or less of that in the first lighting operation. As described above, by suppressing the light intensity of the second lighting operation low, the execution period of the main operation mode can be set to a longer period.
[0140] In addition, in the present invention, ultraviolet light having a peak wavelength within the range of 190 nm or more and less than 240 nm is used to inactivate bacteria, fungi, viruses, etc. present in the environment. As shown in FIG. 11, ultraviolet light with a wavelength of 240 nm or more is not easily absorbed by proteins, and ultraviolet light with a wavelength of 240 nm or less is more easily absorbed as the wavelength approaches 200 nm. Ultraviolet light with a wavelength of 240 nm or more easily penetrates human skin and penetrates into the skin. Therefore, cells inside the human skin are easily damaged. In contrast, ultraviolet light with a wavelength of less than 240 nm is easily absorbed by the surface of human skin (e.g., the stratum corneum) and does not easily penetrate into the skin. Therefore, it is highly safe for the skin.
[0141] Furthermore, ultraviolet light with a wavelength of less than 240 nm is expected to have the effect of inhibiting "photoreactivation of bacteria." Photoreactivation of bacteria is due to the action of photoreactivating enzymes (e.g., FAD (flavin adenine dinucleotide)) that bacteria possess, and when light with a wavelength of 300 nm to 500 nm is irradiated, it acts to repair DNA damage. For example, ultraviolet light with a wavelength of 254 nm, which was previously used as a sterilizing light, inactivates bacteria and viruses by damaging their DNA. However, in a bright environment where sunlight or visible light from white lighting is irradiated, the action of the aforementioned photoreactivating enzymes works to repair DNA damage caused by ultraviolet light (photoreactivation), making it difficult to proceed with inactivation. This problem is more pronounced when ultraviolet light is irradiated temporarily or intermittently, when the light is turned off or the intensity of ultraviolet light is reduced.
[0142] However, it can be seen that the absorption rate for proteins increases significantly in wavelength bands shorter than 240 nm. Therefore, it is effectively absorbed by proteins, which are components of cell membranes and enzymes of bacteria and viruses. In particular, bacteria and viruses are physically much smaller than human cells, and ultraviolet light can easily reach their interiors even in wavelength bands shorter than 240 nm. In other words, ultraviolet light in wavelength bands shorter than 240 nm can inactivate microorganisms and viruses while suppressing adverse effects on humans and animals, and further, it is considered that it acts effectively on cells that constitute bacteria and viruses, especially cell membranes and enzymes containing protein components, and has an effect of suppressing functions such as photoreactivation of bacteria.
[0143] Here, we will explain the differences in the inactivation process of bacteria and the like between continuous lighting and intermittent lighting, in which the effects were confirmed for each wavelength of ultraviolet light.
[0144] The bacteria to be inactivated were Staphylococcus aureus, which possesses photolyase enzyme, and the change in the survival rate of the bacteria was confirmed when the ultraviolet light was turned on continuously and intermittently in an environment irradiated with visible light.
[0145] The ultraviolet light sources used were a low pressure mercury lamp emitting ultraviolet light with a central wavelength of 254 nm, a KrCl excimer lamp emitting ultraviolet light with a central wavelength of 222 nm, and a KrBr excimer lamp emitting ultraviolet light with a central wavelength of 207 nm.
[0146] Continuous lighting is performed by setting the illuminance of the ultraviolet light irradiated on the bacteria to 0.1 mW / cm 2 It was decided.
[0147] The intermittent lighting was set with a lighting time Ta of 50 seconds and a pause time Tb of 59 minutes 10 seconds (3550 seconds) for a lighting duty ratio of 1.39%. The lighting duty ratio is the ratio of the lighting time Ta to the sum of the lighting time Ta and the pause time Tb, and is expressed as Td=Ta / (Ta+Tb). The UV illuminance during intermittent lighting was 0.1 mW / cm 2 The UV radiation dose per lighting operation is 5 mJ / cm 2 It was set to be.
[0148] FIG. 12 shows the results of a comparison between continuous lighting and intermittent lighting using a light source that emits ultraviolet light with a central wavelength of 254 nm, FIG. 13 shows the results of a comparison between continuous lighting and intermittent lighting using a light source that emits ultraviolet light with a central wavelength of 222 nm, and FIG. 14 shows the results of a comparison between continuous lighting and intermittent lighting using a light source that emits ultraviolet light with a central wavelength of 207 nm. In FIG. 12 to FIG. 14, the horizontal axis represents the ultraviolet irradiance (mJ / cm 2 ) and the vertical axis is the log survival rate of bacteria.
[0149] As shown in Figure 12, when UV light with a wavelength of 254 nm is irradiated, the inactivation effect is inferior when the light is intermittently lit compared to when it is continuously lit. This is thought to be because the bacteria recover during the rest period of the intermittent lighting. Thus, UV light with a wavelength of 254 nm causes photoreactivation of the bacteria, so intermittent lighting does not ensure the inactivation of the bacteria. On the other hand, when UV light with a wavelength of 222 nm is irradiated, the photoreactivation of the bacteria is inhibited, so the same inactivation effect is obtained with intermittent lighting and continuous lighting, as shown in Figure 13.
[0150] As shown in Figure 14, it was found that the same inactivation effect was obtained with intermittent and continuous lighting, even in the case of UV irradiation with a wavelength of 207 nm. This is thought to be because UV irradiation inhibits the photoreactivation of the bacteria itself, and is the same result as with UV irradiation with a wavelength of 222 nm. For both light sources, a wavelength selection filter was used to cut out UV light with wavelengths of 240 nm to 300 nm, and UV light in the wavelength band of 190 nm to 240 nm was emitted.
[0151] As described above, it has been confirmed that ultraviolet light in the wavelength band shorter than 240 nm can inactivate microorganisms and viruses while minimizing adverse effects on humans and animals, and furthermore, it acts effectively on the cells that make up bacteria and viruses, in particular cell membranes and enzymes that contain protein components, thereby suppressing functions such as photoreactivation of bacteria. [Explanation of symbols]
[0152] 1 : Inactivation device 2 : Space 10: Housing 10a: Light exit window 11: Human presence sensor 20: Light source section 21: Body 22 : Electrode 30: Control section 31: Arithmetic section 32 : Storage section 33: Drive unit A1: Area H1: Upper region L1: Ultraviolet light d1 : data s1,s2 : Signal pw: power X1 : First period X2 : Second period
Claims
1. A device for inactivating bacteria and viruses present in a space, A light source unit that emits ultraviolet light having a peak wavelength in the range of 190 nm or more and less than 240 nm; and a control unit that controls the light source unit to execute a main operation mode consisting of at least one predetermined operation pattern, the main operation mode including a first lighting operation and a second lighting operation that emits ultraviolet light having a lower light intensity than the first lighting operation.
2. The bacteria or virus inactivation device according to claim 1, characterized in that the control unit controls the light source unit based on the operation pattern set so that, in the main operation mode, the time for which the second lighting operation is continued is longer than the time for which the immediately preceding first lighting operation is continued.
3. The bacteria or virus inactivation device according to claim 1 or 2, characterized in that, in the main operation mode, the control unit controls the light source unit based on the operation pattern set so that the first lighting operation and the second lighting operation are executed periodically.
4. In the main operation mode, the control unit a first control pattern in which the first lighting operation and the first extinguishing operation are alternately performed; The bacterial or viral inactivation device according to claim 1, characterized in that an operating pattern is executed that includes a second control pattern in which the second lighting operation and the extinguishing operation are alternately performed, or the second lighting operation is continued.
5. The bacteria or virus inactivation device according to claim 1, characterized in that the control unit, when detecting that a predetermined condition is satisfied, transitions from the main operation mode to a secondary operation mode different from the main operation mode.
6. A device for inactivating bacteria and viruses present in a space, A light source unit that emits ultraviolet light having a peak wavelength in the range of 190 nm or more and less than 240 nm; a control unit that controls the light source unit to execute a main operation mode including a first lighting operation and a second lighting operation that emits ultraviolet light having a lower light intensity than that of the first lighting operation; A human detection unit that detects whether or not a human is present within a predetermined area, In the main operation mode, the control unit When the human detection unit detects that no human is present, a first control pattern is executed in which the first lighting operation and the extinguishing operation are alternately performed; A bacterial or viral inactivation device characterized in that, when the human detection unit detects the presence of a human, a second control pattern is executed in which the second lighting operation and the extinguishing operation are alternately performed, or the second lighting operation is continued.
7. A device for inactivating bacteria and viruses present in a space, A light source unit that emits ultraviolet light having a peak wavelength in the range of 190 nm or more and less than 240 nm; a control unit that controls the light source unit to execute a main operation mode including a first lighting operation and a second lighting operation that emits ultraviolet light having a lower light intensity than that of the first lighting operation; In the main operation mode, the control unit a third control pattern in which the first lighting operation and the second lighting operation are alternately performed; A bacteria or virus inactivation device characterized by executing control that alternates between the first lighting operation and the second lighting operation, and includes a fourth control pattern in which the second lighting operation is performed more frequently per unit time than the third control pattern.
8. A human detection unit is provided to detect whether or not a human is present within a predetermined area, The bacteria or virus inactivation device described in claim 7, characterized in that the control unit executes the third control pattern when the human detection unit detects that no human is present, and executes the fourth control pattern when the human detection unit detects that a human is present.
9. A method for inactivating bacteria and viruses present in a space, comprising: A method for inactivating bacteria or viruses, comprising a main treatment process for performing an inactivation treatment within the space by carrying out a predetermined operation pattern including a first lighting operation of irradiating a treatment target area with ultraviolet light having a peak wavelength within the range of 190 nm or more and less than 240 nm, and a second lighting operation of irradiating the treatment target area with ultraviolet light having a peak wavelength within the range of 190 nm or more and less than 240 nm and having a lower light intensity than that of the first lighting operation.
10. 10. The method for inactivating bacteria or viruses according to claim 9, wherein the main treatment step is carried out by a light source that emits ultraviolet light and is installed on the ceiling or in an upper area of the space.
11. The method for inactivating bacteria or viruses according to claim 9 or 10, characterized in that the main processing step implements an operation pattern in which the second lighting operation is continued for a longer period of time than the immediately preceding first lighting operation.
12. 11. The bacteria or virus inactivation method according to claim 9 or 10, wherein the main treatment step implements an operation pattern in which the first lighting operation and the second lighting operation are performed periodically.
13. The main processing step includes: a first processing step of alternately performing the first lighting operation and turning off the light; The method for inactivating bacteria or viruses according to claim 9 or 10, characterized in that the operation pattern is carried out including a second processing step of alternating between the second lighting operation and turning off the light, or continuing the second lighting operation.
14. The method for inactivating bacteria or viruses according to claim 9, further comprising a sub-treatment step in which ultraviolet light is irradiated by a treatment step different from the main treatment step when it is detected that a predetermined condition is satisfied.
15. A method for inactivating bacteria and viruses present in a space, comprising: A main processing step includes a first lighting operation of irradiating a processing target area with ultraviolet light having a peak wavelength within a range of 190 nm or more and less than 240 nm, and a second lighting operation of irradiating the processing target area with ultraviolet light having a peak wavelength within a range of 190 nm or more and less than 240 nm and having a lower light intensity than that of the first lighting operation, The main processing step includes: a third processing step of alternately performing the first lighting operation and the second lighting operation; A method for inactivating bacteria or viruses, comprising a fourth treatment step in which the second lighting operation and the first lighting operation are alternately performed and the frequency of the second lighting operation per unit time is higher than that of the third treatment step.
Citation Information
Patent Citations
Apparatus, method, and system for selectively acting on and / or killing bacteria.
JP2014508612A
Indoor sterilizing apparatus
JP2018130535A
Indoor sterilization device and indoor sterilization system
JP2019150668A
Fluid sterilizer
JP2020062599A
System and method for sterilization using ultra-violet illumination
US20200101183A1
